E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer

Area of Science:

• Molecular oncology
• Gene regulation
• Cancer genomics

Background:

• The CDH1 gene, encoding E-cadherin, is a tumor suppressor frequently altered in gastric cancers (GCs).
• CDH1 alterations occur through different mechanisms in diffuse (DGC) and intestinal (IGC) histotypes.
• Understanding CDH1 regulation in IGC is crucial for identifying therapeutic targets and biomarkers.

Purpose of the Study:

• To characterize CDH1 expression in sporadic IGC.
• To investigate the role of microRNAs (miRs) in the transcriptional control of CDH1 in IGC.
• To explore potential molecular mechanisms underlying CDH1 dysregulation in IGC.

Main Methods:

• Quantitative real-time PCR (RT-qPCR) was used to evaluate CDH1 expression in 33 IGC tumor tissues and matched normal tissues.
• RT-qPCR was employed to analyze the expression of 14 predicted regulatory miRs in an independent series of 17 IGCs.
• EZH2 expression, a target of specific miRs, was assessed in IGC samples.

Main Results:

• CDH1 expression was significantly downregulated in IGC tumor tissues compared to normal counterparts (p=0.025).
• miR-101, miR-26b, and miR-200c were significantly downregulated in IGC and confirmed in a larger cohort (p<0.001).
• EZH2 was significantly upregulated in IGC (p=0.005) and inversely correlated with CDH1, miR-101, and miR-26b levels (p<0.001).

Conclusions:

• The study reinforces the association between CDH1 and IGC.
• MicroRNAs play a significant role in the transcriptional control of CDH1 in IGC.
• These findings enhance the understanding of IGC subtypes and identify potential biomarkers for diagnosis and prognosis.